185 related articles for article (PubMed ID: 19684483)
1. Role of prions in neuroprotection and neurodegeneration: a mechanism involving glutamate receptors?
Zamponi GW; Stys PK
Prion; 2009; 3(4):187-9. PubMed ID: 19684483
[TBL] [Abstract][Full Text] [Related]
2. Astrocytic regulation of NMDA receptor subunit composition modulates the toxicity of prion peptide PrP106-126.
Sassoon J; Daniels M; Brown DR
Mol Cell Neurosci; 2004 Jan; 25(1):181-91. PubMed ID: 14962751
[TBL] [Abstract][Full Text] [Related]
3. Molecular basis of cerebral neurodegeneration in prion diseases.
Tatzelt J; Schätzl HM
FEBS J; 2007 Feb; 274(3):606-11. PubMed ID: 17288549
[TBL] [Abstract][Full Text] [Related]
4. Prions activate a p38 MAPK synaptotoxic signaling pathway.
Fang C; Wu B; Le NTT; Imberdis T; Mercer RCC; Harris DA
PLoS Pathog; 2018 Sep; 14(9):e1007283. PubMed ID: 30235355
[TBL] [Abstract][Full Text] [Related]
5. Prions Strongly Reduce NMDA Receptor S-Nitrosylation Levels at Pre-symptomatic and Terminal Stages of Prion Diseases.
Meneghetti E; Gasperini L; Virgilio T; Moda F; Tagliavini F; Benetti F; Legname G
Mol Neurobiol; 2019 Sep; 56(9):6035-6045. PubMed ID: 30710214
[TBL] [Abstract][Full Text] [Related]
6. Protein misfolding and neurodegeneration.
Soto C; Estrada LD
Arch Neurol; 2008 Feb; 65(2):184-9. PubMed ID: 18268186
[TBL] [Abstract][Full Text] [Related]
7. NMDA Receptor and L-Type Calcium Channel Modulate Prion Formation.
Zattoni M; Garrovo C; Xerxa E; Spigolon G; Fisone G; Kristensson K; Legname G
Cell Mol Neurobiol; 2021 Jan; 41(1):191-198. PubMed ID: 32239389
[TBL] [Abstract][Full Text] [Related]
8. The intricate mechanisms of neurodegeneration in prion diseases.
Soto C; Satani N
Trends Mol Med; 2011 Jan; 17(1):14-24. PubMed ID: 20889378
[TBL] [Abstract][Full Text] [Related]
9. Generalization of the prion hypothesis to other neurodegenerative diseases: an imperfect fit.
Guest WC; Silverman JM; Pokrishevsky E; O'Neill MA; Grad LI; Cashman NR
J Toxicol Environ Health A; 2011; 74(22-24):1433-59. PubMed ID: 22043906
[TBL] [Abstract][Full Text] [Related]
10. Copper and prion disease.
Brown DR
Brain Res Bull; 2001 May; 55(2):165-73. PubMed ID: 11470312
[TBL] [Abstract][Full Text] [Related]
11. Molecular mechanisms of glutamate-dependent neurodegeneration in ischemia and traumatic brain injury.
Arundine M; Tymianski M
Cell Mol Life Sci; 2004 Mar; 61(6):657-68. PubMed ID: 15052409
[TBL] [Abstract][Full Text] [Related]
12. Prion neurodegeneration: starts and stops at the synapse.
Mallucci GR
Prion; 2009; 3(4):195-201. PubMed ID: 19887910
[TBL] [Abstract][Full Text] [Related]
13. Neurodegeneration in humans caused by prions.
Prusiner SB
West J Med; 1994 Sep; 161(3):264-72. PubMed ID: 7975565
[TBL] [Abstract][Full Text] [Related]
14. Ionotropic glutamate receptors: still a target for neuroprotection in brain ischemia? Insights from in vitro studies.
Calabresi P; Centonze D; Cupini LM; Costa C; Pisani F; Bernardi G
Neurobiol Dis; 2003 Feb; 12(1):82-8. PubMed ID: 12609492
[TBL] [Abstract][Full Text] [Related]
15. Cellular prion protein null mice display normal AMPA receptor mediated long term depression.
Khosravani H; Zhang Y; Zamponi GW
Prion; 2008; 2(2):48-50. PubMed ID: 19098438
[TBL] [Abstract][Full Text] [Related]
16. Mild mitochondrial inhibition in vivo enhances glutamate-induced neuronal damage through calpain but not caspase activation: role of ionotropic glutamate receptors.
Del Río P; Massieu L
Exp Neurol; 2008 Jul; 212(1):179-88. PubMed ID: 18495118
[TBL] [Abstract][Full Text] [Related]
17. Prions and manganese: A maddening beast.
Brown DR
Metallomics; 2011 Mar; 3(3):229-38. PubMed ID: 21390367
[TBL] [Abstract][Full Text] [Related]
18. Decreased MK-801 binding in discrete hippocampal regions of prion-infected mice.
Diez M; DeArmond SJ; Groth D; Prusiner SB; Hökfelt T
Neurobiol Dis; 2001 Aug; 8(4):692-9. PubMed ID: 11493033
[TBL] [Abstract][Full Text] [Related]
19. Prion protein and copper cooperatively protect neurons by modulating NMDA receptor through S-nitrosylation.
Gasperini L; Meneghetti E; Pastore B; Benetti F; Legname G
Antioxid Redox Signal; 2015 Mar; 22(9):772-84. PubMed ID: 25490055
[TBL] [Abstract][Full Text] [Related]
20. Glutamate N-methyl-D-aspartate and dopamine receptors have contrasting effects on the limbic versus the somatosensory cortex with respect to amphetamine-induced neurodegeneration.
Bowyer JF; Delongchamp RR; Jakab RL
Brain Res; 2004 Dec; 1030(2):234-46. PubMed ID: 15571672
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
